Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED50 ∼ 0.002 mg/...
Similar Items
-
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
by: Novobrantseva, Tatiana I, et al.
Published: (2019) -
The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo
by: Ruda, Vera M., et al.
Published: (2014) -
Lipid-Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo
by: Dong, Yizhou, et al.
Published: (2016) -
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
by: Whitehead, Kathryn Ann, et al.
Published: (2012) -
Lipid-like materials for low-dose, in vivo gene silencing
by: Mahon, Kerry P., et al.
Published: (2011)